Cannabis Marketing Under Health Canada: What's Allowed in 2026

Health Canada's Cannabis Act permits licensed producers to do limited, factual, adult-directed marketing — primarily informational and brand-preference promotion in age-gated channels and direct B2B communication with verified industry professionals — while prohibiting promotion that appeals to youth, makes health or lifestyle claims, uses testimonials, depicts people, or offers inducements. Compliant 2026 cannabis marketing leans on B2B outreach, age-gated owned channels, and fact-based product information.

Intro

The instinct in cannabis marketing is to assume everything is banned. It isn't — but the line between "allowed" and "$1M penalty" is narrow and specific. This guide covers what's actually permitted, the compliant channels that work, what gets brands fined, and how to tell whether a marketing agency can keep you on the right side of the line. For the deep rule-by-rule breakdown of what you can't say, see our Canadian Cannabis Marketing Compliance Playbook.

What Health Canada allows vs prohibits

The Cannabis Act (ss. 17–24) starts from a broad prohibition on promotion, then carves out narrow exceptions. In plain terms:

Generally allowed (within limits):

  • Informational promotion — factual product information (strain, format, cannabinoid content) to adults.

  • Brand-preference promotion — brand name and basic attributes, in spaces where young persons can't access it.

  • B2B communication with verified licensed retailers, producers, and industry professionals — far more room than consumer-facing.

  • Age-gated owned channels — your website, email to age-verified subscribers, where access is controlled.

Prohibited (the lines you don't cross):

  • Anything that could appeal to young persons (Health Canada applies an objective test — intent doesn't matter).

  • Testimonials or endorsements — including star ratings and "customers love it."

  • Lifestyle association — glamour, recreation, excitement, vitality.

  • Depicting a person, character, or animal — real or fictional.

  • Health or therapeutic claims, and false or misleading information.

  • Inducements — discounts, BOGO, contests, loyalty rewards (also restricted provincially).

The 5 compliant channels that actually work

  1. Direct B2B outreach to verified licensed retailers and producers — the highest-leverage, lowest-risk channel. Selling to the trade gives you far more latitude than consumer marketing.

  2. Age-gated owned channels — a website and email program with real age-verification, where you control access and can share factual product information.

  3. Industry trade events and B2B media — conferences, trade publications, and professional channels aimed at the industry, not the public.

  4. Professional networks (LinkedIn) — B2B thought leadership and relationship-building with retailers, LPs, and procurement, kept factual.

  5. Gated educational content — compliant, fact-based resources behind age and audience gates that inform without promoting to youth or making claims.

What gets brands fined

The penalties are not theoretical:

  • Up to $5M and/or 3 years for indictable promotion offences.

  • Up to $1M in administrative monetary penalties — imposed by Health Canada without prosecution.

  • $25,000–$60,000 is a typical cost just to respond to a single provincial (e.g., AGCO) warning letter, between legal fees and rework.

Real-world triggers: "the perfect end to your Friday" (lifestyle), a model holding the product (depicting a person), "4.9/5 from real customers" (testimonial + endorsement), a candy-style brand name (appeal to youth), "BOGO this Friday" (inducement). Each is a routine marketing move that's routine anywhere but cannabis.

Compliant-by-design, in practice

Compliance works best when it's built into the creative from the first draft, not bolted on at the end. Ad-Wise ran an embedded, multi-channel campaign for MedLock, a Canadian cannabis packaging brand, ahead of Grow Up Toronto 2026 — content, lead intelligence, and outreach across email, LinkedIn, and paid, every asset cleared against the Cannabis Act and AGCO rules before it shipped. The pre-show sequence held 60–76% email open rates with no compliance flags. (MedLock's CEO later became an Ad-Wise partner.) That's the model: factual, adult-directed, B2B-led, and reviewed before publish.

How to choose a Health-Canada-compliant marketing agency

Most agencies and ad platforms won't touch cannabis — and many that will don't actually understand the rules. Before you hire, ask:

  • Can they name the specific rules (Cannabis Act sections, AGCO/provincial standards) that govern your work?

  • Do they have a review step that checks every asset against those rules before it ships?

  • Can they show compliant work in the category?

  • Do they treat Quebec (the strictest province) separately?

For the full vetting list, see 37 Questions to Ask Any AI Marketing Agency.

FAQ

Common questions

Yes, within narrow limits. The Cannabis Act permits informational and brand-preference promotion directed at adults in age-gated or controlled spaces, and B2B communication with verified industry professionals. It prohibits youth-appealing content, testimonials, lifestyle association, health claims, and inducements.

Direct B2B outreach to verified licensed retailers and producers. Selling to the trade carries far more latitude and far less risk than consumer-facing promotion, which is tightly restricted.

No. Testimonials and endorsements, including star ratings and 'customers love us' framing, are prohibited. State verifiable product facts yourself instead.

Up to $5M and/or three years for indictable promotion offences, up to $1M in administrative penalties imposed by Health Canada without prosecution, and roughly $25,000 to $60,000 just to respond to a single provincial warning letter.

Yes. On top of the federal Cannabis Act, Ontario (AGCO), BC (LCRB), Alberta (AGLC), and Quebec (CRA) each add standards. Quebec is the strictest and should be treated separately.

Amir G'Nia

© 2026 Ad-Wise

AI at the volume. Humans on strategy.